InvestorsHub Logo
Followers 19
Posts 3022
Boards Moderated 0
Alias Born 09/30/2010

Re: None

Wednesday, 04/13/2011 2:44:34 AM

Wednesday, April 13, 2011 2:44:34 AM

Post# of 279732
Found it, key part of the PR right here. The top bold portion is the key. It shows that ZFN's will be delivered to the notre dame lab as a tool, not a methodology per se. Sigma is creating the zinc fingers customly for us. This is very important for us. The zinc fingers are created to target removal and replacement of genes. I hope everyone gets my drift, there is more to this than I can put into words effectively. Sigma will be very involved in this.

Sigma ZFNs in conjunction with the insertion of more than two hundred proprietary spider silk sequences previously licensed by Kraig from a third party into the silkworm genome. Sigma-Aldrich will be creating customized zinc fingers for Kraig's use in its development of spider silk polymers and technical textiles.

from Sigma's PR today

Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich ® (Nasdaq:SIAL), today announced the signing of an agreement with Kraig Biocraft Laboratories, Inc. (KBLB) to develop genetically modified silkworms for the production of spider silk, using Sigma's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News